BN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Brookfield Corp is not a strong buy for a beginner investor with a long-term strategy at this moment. While the company shows positive financial growth and has strong market confidence as evidenced by its bond offerings, the technical indicators suggest the stock is overbought, and the short-term price trend appears to be uncertain. Additionally, the lack of significant trading signals and mixed analyst ratings further support a cautious approach.
The MACD is positive and contracting, indicating a potential slowdown in upward momentum. RSI is at 81.339, which is in the overbought range, suggesting a potential pullback. The stock is trading near resistance levels (R1: 45.902), with converging moving averages indicating indecision in the price trend.
Strong financial performance in Q4 2025 with revenue up 3.76% YoY, net income up 79.03% YoY, and EPS up 87.50% YoY.
Successful bond offerings with strong market confidence and credit ratings ranging from A- to A
Analyst sentiment from Scotiabank suggests the recent selloff may be overdone.
Overbought technical indicators (RSI at 81.339).
Mixed analyst ratings with recent price target reductions.
No significant hedge fund or insider trading activity.
Short-term stock trend analysis indicates a potential decline in the next week.
In Q4 2025, Brookfield Corp reported a revenue increase of 3.76% YoY to $20.156 billion. Net income surged by 79.03% YoY to $700 million, and EPS grew by 87.50% YoY to $0.3. However, gross margin slightly declined by 0.77% YoY to 25.7%.
Analysts have mixed views. Scotiabank recently lowered its price target to $48.50 but maintained an Outperform rating, citing concerns over credit quality and valuations. Morgan Stanley raised its price target to $60, maintaining an Overweight rating, highlighting ramping deal activity and earnings growth potential.
